Conclusively, this study identified PPP1CA and CTSD as asparagine-related biomarkers driving immune-metabolic crosstalk in T2DM, enhancing the understanding of the pathogenesis of asparagine metabolism in T2DM, which provided novel insights into T2DM mechanisms and potential intervention strategies. Here, CTSD is linked to type 2 diabetes mellitus.